BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 12960320)

  • 1. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets.
    Johnston B; Kim CH; Soler D; Emoto M; Butcher EC
    J Immunol; 2003 Sep; 171(6):2960-9. PubMed ID: 12960320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity.
    Kim CH; Johnston B; Butcher EC
    Blood; 2002 Jul; 100(1):11-6. PubMed ID: 12070001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
    Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
    J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.
    Schaerli P; Willimann K; Lang AB; Lipp M; Loetscher P; Moser B
    J Exp Med; 2000 Dec; 192(11):1553-62. PubMed ID: 11104798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the developmental status of Valpha14i NKT cells play a role in disease?
    Matsuda JL; Gapin L
    Int Rev Immunol; 2007; 26(1-2):5-29. PubMed ID: 17454262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance.
    Jiang X; Shimaoka T; Kojo S; Harada M; Watarai H; Wakao H; Ohkohchi N; Yonehara S; Taniguchi M; Seino K
    J Immunol; 2005 Aug; 175(4):2051-5. PubMed ID: 16081769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor.
    Jenh CH; Cox MA; Hipkin W; Lu T; Pugliese-Sivo C; Gonsiorek W; Chou CC; Narula SK; Zavodny PJ
    Cytokine; 2001 Aug; 15(3):113-21. PubMed ID: 11554781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases.
    Armengol MP; Cardoso-Schmidt CB; Fernández M; Ferrer X; Pujol-Borrell R; Juan M
    J Immunol; 2003 Jun; 170(12):6320-8. PubMed ID: 12794165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling through L-selectin mediates enhanced chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine.
    Subramanian H; Grailer JJ; Ohlrich KC; Rymaszewski AL; Loppnow JJ; Kodera M; Conway RM; Steeber DA
    J Immunol; 2012 Apr; 188(7):3223-36. PubMed ID: 22387549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: developmental switches in chemokine responses during T cell maturation.
    Campbell JJ; Pan J; Butcher EC
    J Immunol; 1999 Sep; 163(5):2353-7. PubMed ID: 10452965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines.
    Ansel KM; McHeyzer-Williams LJ; Ngo VN; McHeyzer-Williams MG; Cyster JG
    J Exp Med; 1999 Oct; 190(8):1123-34. PubMed ID: 10523610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
    Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
    J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration and chemokine receptor pattern of colitis-preventing DX5+NKT cells.
    Hornung M; Werner JM; Farkas S; Schlitt HJ; Geissler EK
    Int J Colorectal Dis; 2011 Nov; 26(11):1423-33. PubMed ID: 21647599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
    Inngjerdingen M; Rolstad B; Ryan JC
    J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation.
    Ebert LM; McColl SR
    J Immunol; 2001 Apr; 166(8):4870-8. PubMed ID: 11290763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1.
    Gunn MD; Ngo VN; Ansel KM; Ekland EH; Cyster JG; Williams LT
    Nature; 1998 Feb; 391(6669):799-803. PubMed ID: 9486651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique lymphotoxin {alpha}beta-dependent pathway regulates thymic emigration of V{alpha}14 invariant natural killer T cells.
    Franki AS; Van Beneden K; Dewint P; Hammond KJ; Lambrecht S; Leclercq G; Kronenberg M; Deforce D; Elewaut D
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9160-5. PubMed ID: 16751279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Valpha14 NKT cells in vitro from hematopoietic precursors residing in bone marrow and peripheral blood.
    Shimamura M; Kobayashi K; Watanabe H; Huang YY; Okamoto N; Kanie O; Goji H; Kobayashi M
    Eur J Immunol; 2004 Mar; 34(3):735-742. PubMed ID: 14991603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of NKT cell differentiation by tissue-specific microenvironments.
    Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
    J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.